HIF1A and pancreatic neoplasm: Analogously, pharmacologic ascorbate (P-AscH) rapidly degrades HIF-1α in a proteasome-dependent pathway in pancreatic cancer cells which is independent of 2-oxoglutarate-dependent prolyl hydroxylase (PHD-2).